Microgravity Biopharmaceuticals - Global Top Players Market Share and Ranking 2026- YH Research

日本语 | 中文

Home > Reports >New Technology > Microgravity Biopharmaceuticals - Global Top Players Market Share and Ranking 2026

Microgravity Biopharmaceuticals - Global Top Players Market Share and Ranking 2026

Publication Date: 2026-01-02
Report Id: 2872431
Industry: New Technology
Report Page: 96
Chart: 98

PDF Download

Publication Date: 2026-01-02
Report Id: 2872431
Industry: New Technology
Report Page: 96
Chart: 98

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Microgravity Biopharmaceuticals Definition
1.2 Global Microgravity Biopharmaceuticals Market Size and Forecast
1.3 Japan Microgravity Biopharmaceuticals Market Size and Forecast
1.4 Share of Japan Microgravity Biopharmaceuticals Market with Respect to the Global Market
1.5 Microgravity Biopharmaceuticals Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Microgravity Biopharmaceuticals Market Dynamics
1.6.1 Microgravity Biopharmaceuticals Market Drivers
1.6.2 Microgravity Biopharmaceuticals Market Restraints
1.6.3 Microgravity Biopharmaceuticals Industry Trends
1.6.4 Microgravity Biopharmaceuticals Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Microgravity Biopharmaceuticals, Global Market Share by Company, 2021-2026
2.2 Global Microgravity Biopharmaceuticals Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Microgravity Biopharmaceuticals Concentration Ratio
2.4 Global Microgravity Biopharmaceuticals Mergers & Acquisitions, Expansion Plans
2.5 Global Microgravity Biopharmaceuticals Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Microgravity Biopharmaceuticals, Japan Market Share by Company, 2021-2026
3.2 Japan Microgravity Biopharmaceuticals Microgravity Biopharmaceuticals Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Microgravity Biopharmaceuticals Industry Chain
4.2 Microgravity Biopharmaceuticals Upstream Analysis
4.2.1 Microgravity Biopharmaceuticals Core Raw Materials
4.2.2 Main Manufacturers of Microgravity Biopharmaceuticals Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Microgravity Biopharmaceuticals Production Mode
4.6 Microgravity Biopharmaceuticals Procurement Model
4.7 Microgravity Biopharmaceuticals Industry Sales Model and Sales Channels
4.7.1 Microgravity Biopharmaceuticals Sales Model
4.7.2 Microgravity Biopharmaceuticals Typical Distributors

5 Sights Microgravity Biopharmaceuticals Market Classification
5.1 Microgravity Biopharmaceuticals Classification by Type
5.1.1 Protein Crystal Growth
5.1.2 Microbial Fermentation
5.1.3 Advanced Disease Model Construction
5.1.4 Others
5.1.5 by Type, Global Microgravity Biopharmaceuticals Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.1.6 by Type, Global Microgravity Biopharmaceuticals Consumption Value, 2021-2032
5.2 Microgravity Biopharmaceuticals Classification by Stage
5.2.1 Drug Discovery
5.2.2 Preclinical Research
5.2.3 Process Development
5.2.4 On-Orbit Production
5.2.5 Others
5.2.6 by Stage, Global Microgravity Biopharmaceuticals Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.2.7 by Stage, Global Microgravity Biopharmaceuticals Consumption Value, 2021-2032

6 Sights by Application
6.1 Microgravity Biopharmaceuticals Segment by Application
6.1.1 New Drug Discovery
6.1.2 Preclinical Research and Translational Medicine
6.1.3 Others
6.2 by Application, Global Microgravity Biopharmaceuticals Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Microgravity Biopharmaceuticals Consumption Value, 2021-2032

7 Sales Sights by Region
7.1 By Region, Global Microgravity Biopharmaceuticals Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Microgravity Biopharmaceuticals Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Microgravity Biopharmaceuticals Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Microgravity Biopharmaceuticals Market Size Market Share
7.4 Europe
7.4.1 Europe Microgravity Biopharmaceuticals Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Microgravity Biopharmaceuticals Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Microgravity Biopharmaceuticals Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Microgravity Biopharmaceuticals Market Size Market Share
7.6 South America
7.6.1 South AmericaMicrogravity Biopharmaceuticals Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Microgravity Biopharmaceuticals Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Microgravity Biopharmaceuticals Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Microgravity Biopharmaceuticals Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Microgravity Biopharmaceuticals Market Size, 2021-2032
8.3.2 by Type, United States Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Microgravity Biopharmaceuticals Market Size, 2021-2032
8.4.2 by Type, Europe Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Microgravity Biopharmaceuticals Market Size, 2021-2032
8.5.2 by Type, China Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Microgravity Biopharmaceuticals Market Size, 2021-2032
8.6.2 by Type, Japan Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Microgravity Biopharmaceuticals Market Size, 2021-2032
8.7.2 by Type, South Korea Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Microgravity Biopharmaceuticals Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Microgravity Biopharmaceuticals Market Size, 2021-2032
8.9.2 by Type, India Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Microgravity Biopharmaceuticals Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Microgravity Biopharmaceuticals Consumption Value Market Share, 2025 VS 2032

9 Company Profile
9.1 BioOrbit
9.1.1 BioOrbit Company Information, Head Office, Market Area, and Industry Position
9.1.2 BioOrbit Company Profile and Main Business
9.1.3 BioOrbit Microgravity Biopharmaceuticals Models, Specifications, and Application
9.1.4 BioOrbit Microgravity Biopharmaceuticals Revenue and Gross Margin, 2021-2026
9.1.5 BioOrbit Recent Developments
9.2 Eascra Biotech
9.2.1 Eascra Biotech Company Information, Head Office, Market Area, and Industry Position
9.2.2 Eascra Biotech Company Profile and Main Business
9.2.3 Eascra Biotech Microgravity Biopharmaceuticals Models, Specifications, and Application
9.2.4 Eascra Biotech Microgravity Biopharmaceuticals Revenue and Gross Margin, 2021-2026
9.2.5 Eascra Biotech Recent Developments
9.3 Exobiosphere
9.3.1 Exobiosphere Company Information, Head Office, Market Area, and Industry Position
9.3.2 Exobiosphere Company Profile and Main Business
9.3.3 Exobiosphere Microgravity Biopharmaceuticals Models, Specifications, and Application
9.3.4 Exobiosphere Microgravity Biopharmaceuticals Revenue and Gross Margin, 2021-2026
9.3.5 Exobiosphere Recent Developments
9.4 Space LiinTech
9.4.1 Space LiinTech Company Information, Head Office, Market Area, and Industry Position
9.4.2 Space LiinTech Company Profile and Main Business
9.4.3 Space LiinTech Microgravity Biopharmaceuticals Models, Specifications, and Application
9.4.4 Space LiinTech Microgravity Biopharmaceuticals Revenue and Gross Margin, 2021-2026
9.4.5 Space LiinTech Recent Developments
9.5 SpacePharma
9.5.1 SpacePharma Company Information, Head Office, Market Area, and Industry Position
9.5.2 SpacePharma Company Profile and Main Business
9.5.3 SpacePharma Microgravity Biopharmaceuticals Models, Specifications, and Application
9.5.4 SpacePharma Microgravity Biopharmaceuticals Revenue and Gross Margin, 2021-2026
9.5.5 SpacePharma Recent Developments
9.6 Varda Space Industries
9.6.1 Varda Space Industries Company Information, Head Office, Market Area, and Industry Position
9.6.2 Varda Space Industries Company Profile and Main Business
9.6.3 Varda Space Industries Microgravity Biopharmaceuticals Models, Specifications, and Application
9.6.4 Varda Space Industries Microgravity Biopharmaceuticals Revenue and Gross Margin, 2021-2026
9.6.5 Varda Space Industries Recent Developments
9.7 Voyager Technologies
9.7.1 Voyager Technologies Company Information, Head Office, Market Area, and Industry Position
9.7.2 Voyager Technologies Company Profile and Main Business
9.7.3 Voyager Technologies Microgravity Biopharmaceuticals Models, Specifications, and Application
9.7.4 Voyager Technologies Microgravity Biopharmaceuticals Revenue and Gross Margin, 2021-2026
9.7.5 Voyager Technologies Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Microgravity Biopharmaceuticals should grow from US$ 69.53 million in 2025 to US$ 133 million by 2032, with a CAGR of 9.6% for the period of 2026-2032.

Microgravity biopharmaceuticals is an interdisciplinary field that utilizes the microgravity environment provided by space stations, sounding rockets, and other similar facilities to conduct research on key aspects of drug development and production. Its core lies in the fact that microgravity can significantly suppress gravity-driven convection and sedimentation effects, thereby creating homogenization conditions that cannot be simulated on Earth. This is primarily used for high-quality protein crystallization and the development of novel drug formulations and efficient production processes. This technology aims to overcome bottlenecks in terrestrial research and development and is one of the most commercially promising directions for space-based biomanufacturing.

Microgravity Biopharmaceuticals

According to YH Research, the global market for Microgravity Biopharmaceuticals should grow from US$ 69.53 million in 2025 to US$ 133 million by 2032, with a CAGR of 9.6% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The microgravity biopharmaceuticals market is at a critical juncture, transitioning from exploratory research to early-stage commercialization. Currently, the market is primarily driven by collaborations between government space agencies and large pharmaceutical companies, focusing on two high-value areas: high-quality protein crystallization and advanced disease model development. As commercial space companies offer more economical launch and platform services, the barriers to entry continue to decrease, attracting a number of biotech startups focused on specific therapeutic areas such as cancer and neurodegenerative diseases. However, the overall market size remains limited, with the vast majority of projects still in the research and validation phase. Future development heavily relies on comparative experiments to definitively demonstrate that microgravity environments can systematically produce commercially viable research results or products superior to those on Earth, ensuring continued industry investment.

This report studies and analyses global Microgravity Biopharmaceuticals status and future trends, to help determine the Microgravity Biopharmaceuticals market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Microgravity Biopharmaceuticals, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Microgravity Biopharmaceuticals market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Microgravity Biopharmaceuticals by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Microgravity Biopharmaceuticals by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Microgravity Biopharmaceuticals key consuming regions, consumption value and demand structure
(5) Microgravity Biopharmaceuticals industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    BioOrbit
    Eascra Biotech
    Exobiosphere
    Space LiinTech
    SpacePharma
    Varda Space Industries
    Voyager Technologies

Market segment by Type, covers
    Protein Crystal Growth
    Microbial Fermentation
    Advanced Disease Model Construction
    Others

Market segment by Stage, covers
    Drug Discovery
    Preclinical Research
    Process Development
    On-Orbit Production
    Others

Market segment by Application, can be divided into
    New Drug Discovery
    Preclinical Research and Translational Medicine
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Microgravity Biopharmaceuticals product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Microgravity Biopharmaceuticals market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Microgravity Biopharmaceuticals market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Microgravity Biopharmaceuticals industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions